Today, patients have access to a much wider range of options, including oromucosal sprays, topical products, transdermal patches, and suppositories. Each route has unique advantages and limitations, and understanding these differences can help patients and healthcare providers make more evidence-informed treatment decisions.
It’s already been five years since recreational cannabis was legalized in Canada. The Cannabis Act was enacted in 2018 and also governs how Canadians can…
In the early years of medical cannabis legalization, patients mostly smoked their medical cannabis, as it was the only legal option at the time.
Since then, other methods of administration (and associated medical formulations) gained recognition and wider acceptance both from patients and prescribers.
Part 1 of this blog post showed some real-world data from the Santé Cannabis observational study and quickly went over chronic pain classification; next…
Disclaimer: this text is written from the perspective of a cisgender woman, who’s learning to be more mindful and inclusive of genders beyond male and…
Pain is part of life, but for some people there is simply no respite from pain. When pain becomes chronic, it’s difficult to make…
Can Medical Cannabis Play a Role? The Opioid Epidemic in North America “Too many Canadians share the heartbreak of losing a loved one to a…
Every year we look forward to the International Cannabinoid Research Society (ICRS) Symposium as it brings together world leaders in the field of cannabis research,…
No two cases of Multiple Sclerosis (MS) look the same – the trajectories, outcomes, symptoms and experiences of those living with MS vary from person…
Using medical cannabis to treat … a cannabis use disorder? While the concept might seem counterintuitive, preclinical research and evidence from clinical trials suggest targeting…